BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 24396515)

  • 1. Prospective of ⁶⁸Ga-radiopharmaceutical development.
    Velikyan I
    Theranostics; 2013 Dec; 4(1):47-80. PubMed ID: 24396515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals.
    Fani M; André JP; Maecke HR
    Contrast Media Mol Imaging; 2008; 3(2):67-77. PubMed ID: 18383558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectives.
    Breeman WA; de Blois E; Sze Chan H; Konijnenberg M; Kwekkeboom DJ; Krenning EP
    Semin Nucl Med; 2011 Jul; 41(4):314-21. PubMed ID: 21624565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gallium-68: methodology and novel radiotracers for positron emission tomography (2012-2017).
    Tanzey SS; Thompson S; Scott PJ; Brooks AF
    Pharm Pat Anal; 2018 Sep; 7(5):193-227. PubMed ID: 30066605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biodistribution of lipophilic and monocationic gallium radiopharmaceuticals derived from N,N'-bis(3-aminopropyl)-N,N'-dimethylethylenediamine: potential agents for PET myocardial imaging with 68Ga.
    Hsiao YM; Mathias CJ; Wey SP; Fanwick PE; Green MA
    Nucl Med Biol; 2009 Jan; 36(1):39-45. PubMed ID: 19181267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclotron Production of PET Radiometals in Liquid Targets: Aspects and Prospects.
    Pandey MK; DeGrado TR
    Curr Radiopharm; 2021; 14(4):325-339. PubMed ID: 32867656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Rapid and Specific HPLC Method to Determine Chemical and Radiochemical Purity of [
    Migliari S; Sammartano A; Scarlattei M; Baldari G; Silva C; Ruffini L
    Curr Radiopharm; 2021; 14(2):121-130. PubMed ID: 32990551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Past, present and future of 68Ge/68Ga generators.
    Rösch F
    Appl Radiat Isot; 2013 Jun; 76():24-30. PubMed ID: 23245638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A generator-produced gallium-68 radiopharmaceutical for PET imaging of myocardial perfusion.
    Sharma V; Sivapackiam J; Harpstrite SE; Prior JL; Gu H; Rath NP; Piwnica-Worms D
    PLoS One; 2014; 9(10):e109361. PubMed ID: 25353349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of CGMP production of 18F- and 68Ga-radiopharmaceuticals.
    Chi YT; Chu PC; Chao HY; Shieh WC; Chen CC
    Biomed Res Int; 2014; 2014():680195. PubMed ID: 25276810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continued rapid growth in (68) Ga applications: update 2013 to June 2014.
    Velikyan I
    J Labelled Comp Radiopharm; 2015 Mar; 58(3):99-121. PubMed ID: 25689590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emitting [68Ga]Ga-based imaging agents: chemistry and diversity.
    Velikyan I
    Med Chem; 2011 Sep; 7(5):345-79. PubMed ID: 21711223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gallium-68: a new trend in PET radiopharmacy.
    Prata MI
    Curr Radiopharm; 2012 Apr; 5(2):142-9. PubMed ID: 22280116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 68Ga-Based radiopharmaceuticals: production and application relationship.
    Velikyan I
    Molecules; 2015 Jul; 20(7):12913-43. PubMed ID: 26193247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, Characterization, and Radiolabeling of [
    Ashhar Z; Yusof NA; Ahmad Saad FF; Mohd Nor SM; Mohammad F; Bahrin Wan Kamal WH; Hassan MH; Ahmad Hassali H; Al-Lohedan HA
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32526838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET).
    Shokeen M; Anderson CJ
    Acc Chem Res; 2009 Jul; 42(7):832-41. PubMed ID: 19530674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A methodical 68Ga-labelling study of DO2A-(butyl-L-tyrosine)2 with cation-exchanger post-processed 68Ga: practical aspects of radiolabelling.
    Riss PJ; Burchardt C; Roesch F
    Contrast Media Mol Imaging; 2011; 6(6):492-8. PubMed ID: 22144027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The renaissance of the ⁶⁸Ge/⁶⁸Ga radionuclide generator initiates new developments in ⁶⁸Ga radiopharmaceutical chemistry.
    Roesch F; Riss PJ
    Curr Top Med Chem; 2010; 10(16):1633-68. PubMed ID: 20583984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of
    Rodnick ME; Sollert C; Stark D; Clark M; Katsifis A; Hockley BG; Parr DC; Frigell J; Henderson BD; Bruton L; Preshlock S; Abghari-Gerst M; Piert MR; Fulham MJ; Eberl S; Gagnon K; Scott PJH
    Nat Protoc; 2022 Apr; 17(4):980-1003. PubMed ID: 35246649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (64)Cu- and (68)Ga-Based PET Imaging of Folate Receptor-Positive Tumors: Development and Evaluation of an Albumin-Binding NODAGA-Folate.
    Farkas R; Siwowska K; Ametamey SM; Schibli R; van der Meulen NP; Müller C
    Mol Pharm; 2016 Jun; 13(6):1979-87. PubMed ID: 27145400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.